SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-053240
Filing Date
2023-10-20
Accepted
2023-10-20 16:12:45
Documents
2
Period of Report
2023-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1562
2 POA DOCUMENT poa.txt EX-24 3357
  Complete submission text file 0001209191-23-053240.txt   6362
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 PA 19341
Business Address
Lechleider Robert (Reporting) CIK: 0001997584 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39580 | Film No.: 231337297